As 2026 begins, the regulatory bottleneck that once slowed the adoption of AI-driven genomics is being dismantled by a wave of international policy harmonization. The new "Global Genomic Compact," signed by 45 nations in early 2026, establishes a unified framework for validating AI-derived clinical evidence. This allows a diagnostic tool approved in Seoul to be fast-tracked for use in Toronto...
Tiếng Việt 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)